Maulana, Moch. Iqbal and -, dr. Anika Candrasari, M. Kes (2018) Perbandingan Tingkat Kejadian Hipermenorea Antara Penggunaan KB Suntik Depo Provera dan Cyclofem Di Puskesmas Kalasan Purwomartani Sleman Yogyakarta. Skripsi thesis, Universitas Muhammadiyah Surakarta.
PDF (Naskah Publikasi)
NASKAH PUBLIKASI IQBAL.pdf Download (661kB) |
|
PDF (Halaman Depan)
HALAMAN DEPAN.pdf Download (1MB) |
|
PDF (Bab I)
BAB I.pdf Download (278kB) |
|
PDF (Bab II)
BAB II.pdf Restricted to Repository staff only Download (325kB) | Request a copy |
|
PDF (Bab III)
BAB III.pdf Restricted to Repository staff only Download (244kB) | Request a copy |
|
PDF (Bab IV)
BAB IV.pdf Restricted to Repository staff only Download (305kB) | Request a copy |
|
PDF (Bab V)
BAB V.pdf Restricted to Repository staff only Download (103kB) | Request a copy |
|
PDF (Daftar Pustaka)
DAFTAR PUSTAKA.pdf Download (108kB) |
|
PDF (Lampiran)
LAMPIRAN.pdf Restricted to Repository staff only Download (1MB) | Request a copy |
|
PDF (Pernyataan Publikasi Ilmiah)
SURAT PERNYATAAN PUBLIKASI ILMIAH.pdf Restricted to Repository staff only Download (380kB) | Request a copy |
Abstract
Background: One of the contraceptives that many users in Indonesia are injecting contraceptives of both types Cyclofem and Depo Provera. Cyclofem is a contraceptive containing estrogen and prosteron use once a month. While Depo Provera contains only progesterone use once for three months. Use of injectable contraception is thought to cause complications or side effects. One of them is Hypermenorrhea . Purpose: To analyze the incidence of Hypermenorreha between Depo Provera and Cyclofem in Kalasan Health Center Yogyakarta 2016 Method: Sampling method using questionnaire by taking samples of 60 respondents, research method used in this study is a cross sectional method and using a retrospective approach and Chi Square statistical test Results: The results showed that Cyclofem respondents who experienced Hypermenorreha incidence as much as 43.3% and who did not experience an incidence of 56.7%. While Depo Provera respondents who experienced the incidence of Hypermenorreha is as much as 63.3% and who did not experience the incidence of 36.7%. Based on the statistical calculation, Chi Square score of 0.196 (P>0,05) means that there is no difference in the use of injectable contraception type (Cyclofem and Depo Provera) on the respondent's Hypermenorreha Conclusion: There is no difference between the use injectable conraception of Cyclofem and Depo Provera at the incidence of Hypermenorrhoea at Kalasan Yogyakarta Health Center 2016 Keywords: Depo Provera, Cyclofem, Hypermenorrhea, Injectable Contraception
Item Type: | Karya ilmiah (Skripsi) |
---|---|
Uncontrolled Keywords: | Cyclofem, Depo Provera , Hipermenorea, Kontrasepsi Suntik |
Subjects: | R Medicine > R Medicine (General) |
Divisions: | Fakultas Kedokteran |
Depositing User: | MOCH IQBAL MAULANA |
Date Deposited: | 11 May 2018 07:19 |
Last Modified: | 11 May 2018 07:19 |
URI: | http://eprints.ums.ac.id/id/eprint/62543 |
Actions (login required)
View Item |